Akebia Therapeutics: Q1 Earnings Snapshot

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Thursday reported a loss of $18 million in its first quarter.

The Cambridge, Massachusetts-based company said it had a loss of 9 cents per share.

The kidney disease treatment developer posted revenue of $32.6 million in the period.

The company’s shares closed at $1.40. A year ago, they were trading at $1.06.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKBA at https://www.zacks.com/ap/AKBA

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up